Long-term follow-up of bilateral sporadic renal tumors

Urology

Volumn 61, Issue 5, 2003, Pages 921-925

  Patel, Manish I ^a   Simmons, Rachel ^a   Kattan, Michael W ^a   Motzer, Robert J ^a   Reuter, Victor E ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; KIDNEY CARCINOMA; KIDNEY TUMOR; LONG TERM CARE; NEPHRECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; REGRESSION ANALYSIS;

EID: 0037625645     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02578-5     Document Type: Article

References (23)

1. Marshall F.F., Stewart A.K., Menck H.R. The National Cancer Data Base report on kidney cancers. The American College of Surgeons Commission on Cancer and the American Cancer Society . Cancer. 80:1997;2167-2174.
2. Choyke P.L., Glenn G.M., Walther M.M., et al. The natural history of renal lesions in von Hippel-Lindau disease a serial CT study in 28 patients . Am J Roentgenol. 159:1992;1229-1234.
3. Frydenberg M., Malek R.S., Zincke H. Conservative renal surgery for renal cell carcinoma in von Hippel-Lindau's disease. J Urol. 149:1993;461-464.
4. Couch V., Lindor N.M., Karnes P.S., et al. von Hippel-Lindau disease. Mayo Clin Proc. 75:2000;265-272.
5. Toro J.R., Glenn G., Duray P., et al. Birt-Hogg-Dube syndrome a novel marker of kidney neoplasia . Arch Dermatol. 135:1999;1195-1202.
6. Marberger M., Pugh R.C., Auvert J., et al. Conservation surgery of renal carcinoma the EIRSS experience . Br J Urol. 53:1981;528-532.
7. Novick A.C., Streem S., Montie J.E., et al. Conservative surgery for renal cell carcinoma a single-center experience with 100 patients . J Urol. 141:1989;835-839.
8. Grimaldi G., Reuter V., Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol. 5:1998;548-552.
9. Guinan P., Sobin L.H., Algaba F., et al. TNM staging of renal cell carcinoma Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) . Cancer. 80:1997;992-993.
10. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumours. J Pathol. 183:1997;131-133.
11. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Jacobs S.C., Berg S.I., Lawson R.K. Synchronous bilateral renal cell carcinoma total surgical excision . Cancer. 46:1980;2341-2345.
13. Blute M.L., Amling C.L., Bryant S.C., et al. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Mayo Clin Proc. 75:2000;1020-1026.
14. Black J., Rotellar C., Rakowski T.A., et al. Bilateral nephrectomy and dialysis as an option for patients with bilateral renal cancer. Nephron. 49:1988;150-153.
15. Lee C.T., Katz J., Shi W., et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 163:2000;730-736.
16. Lau W.K., Blute M.L., Weaver A.L., et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 75:2000;1236-1242.
17. McKiernan J., Simmons R., Katz J., et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 59:2002;816-820.
18. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors indications, techniques and outcomes . J Urol. 166:2001;6-18.
19. Walther M.M., Lubensky I.A., Venzon D., et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease clinical implications . J Urol. 154:1995;2010-2014.
20. Schmidt L., Duh F.M., Chen F., et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 16:1997;68-73.
21. Zbar B., Tory K., Merino M., et al. Hereditary papillary renal cell carcinoma. J Urol. 151:1994;561-566.
22. Crotty T.B., Farrow G.M., Lieber M.M. Chromophobe cell renal carcinoma clinicopathological features of 50 cases . J Urol. 154:1995;964-967.
23. Mancilla-Jimenez R., Stanley R.J., Blath R.A. Papillary renal cell carcinoma a clinical, radiologic, and pathologic study of 34 cases . Cancer. 38:1976;2469-2480.